Trial site
Institute of Hematology and Blood Transfusion
- 17running trials
- 4closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia8 trials
- Acute myeloid leukaemia5 trials
- Myelodysplastic syndromes5 trials
- Myeloproliferative neoplasms5 trials
- Chronic myeloid leukaemia3 trials
- Childhood cancers2 trials
- Chronic lymphocytic leukaemia2 trials
- Haemophilia2 trials
- Hodgkin lymphoma1 trial
- Mantle cell lymphoma1 trial
- Phase
- Phase 310 trials
- Phase 25 trials
- Phase 1/23 trials
- Phase 42 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Recruiting10 trials
- Not yet recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Institute of Hematology and Blood Transfusion, Czech Republic4 trials
- Novartis Pharmaceuticals3 trials
- Swedish Orphan Biovitrum AB (publ)2 trials
- Ascentage Pharma Group Inc.1 trial
- AstraZeneca1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia5 recruiting
- Myeloproliferative neoplasms4 recruiting
- Myelodysplastic syndromes3 recruiting
- Acute myeloid leukaemia2 recruiting
- Childhood cancers2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Chronic myeloid leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
Closed trials
Completed
Completed
Terminated
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026